Abstract
Anti-N-methyl-D-aspartate receptor encephalitis is a neuroimmunologic disorder that has been increasingly diagnosed during the past 5 years. It provokes a predictable syndrome treated with several immunomodulatory agents, such as corticosteroids and/or biologics. We managed a child with this disease who developed Pneumocystis jirovecii pneumonia as a direct infectious complication of the use of rituximab.
MeSH terms
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / drug therapy*
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / microbiology*
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / pathology
-
Anti-N-Methyl-D-Aspartate Receptor Encephalitis / virology
-
Biological Products / adverse effects
-
Biological Products / therapeutic use
-
Humans
-
Immunologic Factors / therapeutic use
-
Infant
-
Male
-
Pneumocystis carinii / isolation & purification*
-
Pneumonia, Pneumocystis / drug therapy*
-
Pneumonia, Pneumocystis / pathology*
-
Rituximab / adverse effects
-
Rituximab / therapeutic use
Substances
-
Biological Products
-
Immunologic Factors
-
Rituximab